Literature DB >> 35399110

Arterial spin labeling imaging for the detection of cerebral blood flow asymmetry in patients with corticobasal syndrome.

Tomohisa Yamaguchi1, Masamichi Ikawa2,3,4, Souichi Enomoto1, Norimichi Shirafuji1, Osamu Yamamura1, Tetsuya Tsujikawa5, Hidehiko Okazawa5, Hirohiko Kimura6, Yasunari Nakamoto1, Tadanori Hamano1,7.   

Abstract

PURPOSE: Corticobasal syndrome (CBS) and Parkinson's disease (PD) both present with asymmetrical extrapyramidal symptoms, often leading to a diagnostic dilemma. Patients with CBS frequently show cerebral blood flow (CBF) asymmetry alongside asymmetrical cortical atrophy. This study aimed to evaluate the clinical utility of arterial spin labeling (ASL) magnetic resonance imaging (MRI) to detect CBF asymmetry in patients with CBS.
METHODS: We retrospectively investigated asymmetries of regional CBF and cortical volume, measured using ASL and T1-weighted MRI, in 13 patients with CBS and 22 age-matched patients with PD. Regional CBF and cortical volume values were derived from nine brain regions on each side. CBF and volume asymmetries were calculated as %difference in each region, respectively.
RESULTS: CBF asymmetry showed significantly greater differences in seven of nine regions, such as the perirolandic area (- 8.7% vs. - 1.4%, p < 0.001) and parietal cortex (- 9.7% vs. - 1.3%, p < 0.001) in patients with CBS compared with patients with PD. In contrast, significant differences in volume asymmetry were observed in three regions included within the seven regions showing CBF asymmetry, which indicated that CBF asymmetry has greater sensitivity than volume asymmetry to detect asymmetricity in CBS.
CONCLUSION: ASL imaging showed significant CBF asymmetry in a wider range of brain regions in patients with CBS, which suggests that noninvasive MRI with ASL imaging is a promising tool for the diagnosis of CBS, with advantages that include the simultaneous evaluation of asymmetrical hypoperfusion in addition to focal atrophy.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Arterial spin labeling; Asymmetry; Cerebral blood flow; Corticobasal syndrome; Parkinson’s disease

Mesh:

Substances:

Year:  2022        PMID: 35399110     DOI: 10.1007/s00234-022-02942-9

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.995


  32 in total

1.  Diagnostic criteria for corticobasal syndrome: a comparative study.

Authors:  Robert Mathew; Thomas H Bak; John R Hodges
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-10-21       Impact factor: 10.154

Review 2.  Corticobasal syndrome: neuroimaging and neurophysiological advances.

Authors:  F Di Stasio; A Suppa; L Marsili; N Upadhyay; F Asci; M Bologna; C Colosimo; G Fabbrini; P Pantano; A Berardelli
Journal:  Eur J Neurol       Date:  2019-03-15       Impact factor: 6.089

3.  Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy.

Authors:  P Soliveri; D Monza; D Paridi; D Radice; M Grisoli; D Testa; M Savoiardo; F Girotti
Journal:  Neurology       Date:  1999-08-11       Impact factor: 9.910

4.  Office of Rare Diseases neuropathologic criteria for corticobasal degeneration.

Authors:  D W Dickson; C Bergeron; S S Chin; C Duyckaerts; D Horoupian; K Ikeda; K Jellinger; P L Lantos; C F Lippa; S S Mirra; M Tabaton; J P Vonsattel; K Wakabayashi; I Litvan
Journal:  J Neuropathol Exp Neurol       Date:  2002-11       Impact factor: 3.685

5.  Corticobasal degeneration: evaluation of cortical atrophy by means of hemispheric surface display generated with MR images.

Authors:  H Kitagaki; N Hirono; K Ishii; E Mori
Journal:  Radiology       Date:  2000-07       Impact factor: 11.105

6.  Pathologic heterogeneity in clinically diagnosed corticobasal degeneration.

Authors:  B F Boeve; D M Maraganore; J E Parisi; J E Ahlskog; N Graff-Radford; R J Caselli; D W Dickson; E Kokmen; R C Petersen
Journal:  Neurology       Date:  1999-09-11       Impact factor: 9.910

7.  Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease.

Authors:  Esther Cubo; Pablo Martinez Martín; Jesus A Martin-Gonzalez; Carmen Rodríguez-Blázquez; Jaime Kulisevsky
Journal:  Mov Disord       Date:  2010-01-15       Impact factor: 10.338

8.  Brain perfusion SPECT in patients with corticobasal degeneration: analysis using statistical parametric mapping.

Authors:  A K M Moinul Hossain; Yuji Murata; Lin Zhang; Shin-ichi Taura; Yukinobu Saitoh; Hidehiro Mizusawa; Kenji Oda; Eisuke Matsushima; Yoshiro Okubo; Hitoshi Shibuya
Journal:  Mov Disord       Date:  2003-06       Impact factor: 10.338

9.  Criteria for the diagnosis of corticobasal degeneration.

Authors:  Melissa J Armstrong; Irene Litvan; Anthony E Lang; Thomas H Bak; Kailash P Bhatia; Barbara Borroni; Adam L Boxer; Dennis W Dickson; Murray Grossman; Mark Hallett; Keith A Josephs; Andrew Kertesz; Suzee E Lee; Bruce L Miller; Stephen G Reich; David E Riley; Eduardo Tolosa; Alexander I Tröster; Marie Vidailhet; William J Weiner
Journal:  Neurology       Date:  2013-01-29       Impact factor: 9.910

10.  Differential diagnosis of parkinsonian syndromes using dopamine transporter and perfusion SPECT.

Authors:  Shigetoshi Takaya; Nobukatsu Sawamoto; Tomohisa Okada; Gosuke Okubo; Sei Nishida; Kaori Togashi; Hidenao Fukuyama; Ryosuke Takahashi
Journal:  Parkinsonism Relat Disord       Date:  2017-11-14       Impact factor: 4.891

View more
  1 in total

1.  The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes.

Authors:  Piotr Alster; Natalia Madetko; Bartosz Migda; Michał Nieciecki; Michał Kutyłowski; Leszek Królicki; Andrzej Friedman
Journal:  Diagnostics (Basel)       Date:  2022-07-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.